◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Anuh Pharma Limited (ANUHPHR) Financial History

Name: Anuh Pharma Limited (ANUHPHR) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Anuh Pharma Limited (ANUHPHR) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Mumbai, India with about 323 employees. Its market capitalization is roughly ₹9 billion. In the fiscal year ended 2026-03-31, ANUHPHR reported ₹7.7B in revenue and ₹410M in net income.

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India.

Interactive charts & full statements →

ANUHPHR Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹7.7B	₹6.6B	₹6.5B	₹5.3B
Gross Profit	₹1.7B	₹1.6B	₹1.6B	₹1.3B
Operating Income (EBIT)	₹569M	₹568M	₹677M	₹444M
Net Income	₹410M	₹474M	₹601M	₹362M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANUHPHR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹1.9B	₹2.0B	₹2.0B	₹1.9B	₹1.9B
Gross Profit	₹455M	₹509M	₹459M	₹414M	₹339M
Operating Income (EBIT)	₹138M	₹169M	₹138M	₹90M	₹78M
Net Income	₹114M	₹117M	₹134M	₹76M	₹83M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANUHPHR Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹150M)	(₹125M)	(₹100M)	(₹88M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANUHPHR Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹5.6B	₹5.1B	₹4.5B	₹4.0B	—
Total Liabilities	₹2.1B	₹1.8B	₹1.5B	₹1.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANUHPHR viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

SIGACHI · Sigachi Industries Limited — ₹11 billion
BAJAJHCARE · Bajaj HealthCare Limited — ₹11 billion
1681 · Consun Pharmaceutical Group Limited — HK$11 billion
4512 · Wakamoto Pharmaceutical Co.,Ltd. — JPY 10 billion
4524 · Morishita Jintan Co., Ltd. — JPY 9 billion
SGRL · Shree Ganesh Remedies Limited — ₹9 billion
2005 · SSY Group Limited — HK$8 billion
WANBURY · Wanbury Limited — ₹8 billion

← ANTX All “A” companies ANUP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.